Lates News

aTyr Pharma (ATYR.US): The Q3 2025 financial report showed revenue of $0, compared to $0 in the previous quarter, and an expected value of $4.8 million. Earnings per share were -$0.26, compared to -$0.23 in the previous quarter, with an expected value of -$0.19.